Goto S, Hamano T, Taniguchi M, Abe M, Nitta K, Nishi S
Sci Rep. 2025; 15(1):8089.
PMID: 40057535
PMC: 11890868.
DOI: 10.1038/s41598-025-92359-0.
Kato K, Nakashima A, Morishita M, Ohkido I, Yokoo T
Clin Kidney J. 2025; 18(2):sfae391.
PMID: 39927252
PMC: 11803308.
DOI: 10.1093/ckj/sfae391.
Akizawa T, Urano N, Ikejiri K, Nakanishi K, Fukagawa M
Ther Apher Dial. 2025; 29(2):157-169.
PMID: 39829064
PMC: 11879479.
DOI: 10.1111/1744-9987.14241.
Shimamoto S, Nakahara T, Yamada S, Nagasu H, Kishi S, Nakashima N
Sci Rep. 2024; 14(1):27481.
PMID: 39523380
PMC: 11551138.
DOI: 10.1038/s41598-024-79291-5.
Jadoul M, Labriola L
Kidney Int Rep. 2024; 9(10):2854-2856.
PMID: 39430190
PMC: 11489494.
DOI: 10.1016/j.ekir.2024.08.023.
The benefit of reduced serum phosphate levels depends on patient characteristics: a nationwide prospective cohort study.
Goto S, Hamano T, Fujii H, Taniguchi M, Abe M, Nitta K
Clin Kidney J. 2024; 17(10):sfae263.
PMID: 39385948
PMC: 11462437.
DOI: 10.1093/ckj/sfae263.
Long-Term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-Label 52-Week Study.
Hamano T, Koiwa F, Isaka Y, Yokoyama K, Fukagawa M, Inagaki Y
Am J Nephrol. 2024; 56(1):70-84.
PMID: 39299219
PMC: 11812589.
DOI: 10.1159/000541493.
Association between CKD-MBD and hip-bone microstructures in dialysis patients.
Iseri K, Mizobuchi M, Shishido K, Hida N
Clin Kidney J. 2024; 17(8):sfae240.
PMID: 39188768
PMC: 11345638.
DOI: 10.1093/ckj/sfae240.
Parathyroid carcinoma in a dialysis patient definitively diagnosed after parathyroidectomy for uncontrolled secondary hyperparathyroidism.
Tatsumi R, Tomita Y, Takiguchi S, Uehara S, Nakamura M
CEN Case Rep. 2024; .
PMID: 39158827
DOI: 10.1007/s13730-024-00924-9.
Comparison of serum alkaline phosphatase levels between two measurement methods in chronic hemodialysis patients in Japan: involvement of ABO blood group system and relationship with mortality risk.
Nagano N, Tagahara A, Shimada T, Miya M, Tamei N, Muto S
Clin Exp Nephrol. 2024; 28(12):1300-1310.
PMID: 39110345
DOI: 10.1007/s10157-024-02540-4.
Association Between Disturbed Serum Phosphorus Levels and QT Interval Prolongation.
Sasaki S, Fujisaki K, Nishimura M, Nakano T, Abe M, Hanafusa N
Kidney Int Rep. 2024; 9(6):1792-1801.
PMID: 38899225
PMC: 11184388.
DOI: 10.1016/j.ekir.2024.03.007.
Correlation between serum phosphate and all-cause mortality in critically ill patients with coronary heart disease accompanied by chronic kidney disease: a retrospective study using the MIMIC-IV database.
He M, Ren S, Lin Y, Zeng X
Front Cardiovasc Med. 2024; 11:1371000.
PMID: 38883990
PMC: 11176493.
DOI: 10.3389/fcvm.2024.1371000.
Association of calciprotein particles with serum phosphorus among patients undergoing conventional and extended-hours haemodialysis.
Nishibori N, Okazaki M, Miura Y, Hishida M, Kurasawa S, Imaizumi T
Clin Kidney J. 2024; 17(6):sfae121.
PMID: 38873576
PMC: 11170037.
DOI: 10.1093/ckj/sfae121.
Primary adrenal insufficiency developed 22 years after the diagnosis of light and heavy chain deposition disease: a case report.
Eguchi E
CEN Case Rep. 2024; 13(6):545-551.
PMID: 38767838
PMC: 11608181.
DOI: 10.1007/s13730-024-00893-z.
Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPS.
Yamamoto S, Jorgensen H, Zhao J, Karaboyas A, Komaba H, Vervloet M
Kidney Int Rep. 2024; 9(4):863-876.
PMID: 38765600
PMC: 11101738.
DOI: 10.1016/j.ekir.2024.01.002.
Framework of Guidelines for Management of CKD in Asia.
Pollock C, Moon J, Ngoc Ha L, Gojaseni P, Ching C, Gomez L
Kidney Int Rep. 2024; 9(4):752-790.
PMID: 38765566
PMC: 11101746.
DOI: 10.1016/j.ekir.2023.12.010.
Roles of Parathyroid Hormone and Fibroblast Growth Factor 23 in Advanced Chronic Kidney Disease.
Nakagawa Y, Komaba H
Endocrinol Metab (Seoul). 2024; 39(3):407-415.
PMID: 38752265
PMC: 11220210.
DOI: 10.3803/EnM.2024.1978.
Pre-Transplant Calcimimetic Use and Dose Information Improves the Accuracy of Prediction of Tertiary Hyperparathyroidism after Kidney Transplantation: A Retrospective Cohort Study.
Okada M, Sato T, Himeno T, Hasegawa Y, Futamura K, Hiramitsu T
Transpl Int. 2024; 37:12704.
PMID: 38751772
PMC: 11095396.
DOI: 10.3389/ti.2024.12704.
The 100 top-cited articles on chronic kidney disease-mineral and bone disorder: A bibliometric analysis.
Kang T, Mao H, Zhang D, Tang D, Ou S
Medicine (Baltimore). 2024; 103(16):e37835.
PMID: 38640280
PMC: 11029964.
DOI: 10.1097/MD.0000000000037835.
Increased risk of hypocalcemia with decreased kidney function in patients prescribed bisphosphonates based on real-world data from the MID-NET in Japan: a new-user cohort study.
Hasegawa T, Komamine M, Ishiguro C, Motomura H, Kajiyama K, Nonaka T
BMC Nephrol. 2024; 25(1):134.
PMID: 38622507
PMC: 11017550.
DOI: 10.1186/s12882-024-03553-7.
